Analyst Reports Day Trading Economy Finance Health Care BioNTech & Cardiol Therapeutics – on the verge of a breakout BioNTech and Pfizer suffers a defeat in a patent dispute, and Cardiol Therapeutics expects significant topline results from a Phase II study. Stefan Feulner5 mins22 May 2024 15:00 (EDT)
Contributors & Collaborations Health Care Leaders Market News Takeover rumours: BioNTech, Cardiol Therapeutics and Novo Nordisk in focus Biotech has lagged behind the performance of artificial intelligence and high-tech this year, but economic conditions might signal changes. André Will-Laudien6 mins24 April 2024 13:04 (EDT)
